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   ABSTRACT 
 
Background: Melasma is an acquired, chro-
nic hypermelanosis condition. Melasma is more 
common in women of all races and occur espe-
cially on the face. The pathogenesis of melasma 
is very complex and the treatment is still a 
challenge. The purpose of this study was to 
report mixed-type melasma treated with low 
fluence Q-switched Nd-YAG 1064 nm laser. 
Case Presentation: A case of melasma in 54 
year old woman was reported. Dermatological 
examination showed presence of brownish 
macules and patches in the centro facial area 
with symmetrical distribution. Examination 
with wood lamp showed mixed type. Patients 
have received topical therapy but there were no 
improvement.  
Results: The patient was then treated with low 
fluence Q-switched Nd-YAG 1064 nm laser for 
three sessions with an interval of 2 weeks. At 6 
weeks of treatment the modified MASI 
(mMASI) value was reduced from 8.4 to 4.6 
and the VAS value was increased from 2 to 8.  
Conclusion: The depth of the pigment deter-
mined the response to therapy. In the mixed 
type melasma the response for therapy is only 
partial. The low-fluence Q-switched Nd-YAG 
1064 nm laser can penetrate deeper into the 
dermis and damage melanin in a short time. 
 
Keywords: mixed typed melasma, low 
fluence, Q-switched Nd-YAG laser  
 
Correspondence:  
Aninda Fitri Nugrahani. Department of Derma-
tology and Venereology, DR. Saiful Anwar 
Hospital, Malang, East Java/ Faculty of Medi-
cine, Universitas Brawijaya, Malang, East Java. 
Email: aninda16fitri@gmail.com 
 
Cite this as: 
Nugrahani AF, Murlistyarini S (2020). Mixed-Type Melasma Treated with Low Fluence Q-Switched Nd-
YAG 1064 nm Laser: A Case Report. Indones J Med. 05(02): 95-101. https://doi.org/10.26911/theijmed.20-
20.05.02.01. 
Indonesian Journal of Medicine is licensed under a Creative Commons  
Attribution-NonCommercial-ShareAlike 4.0 International License. 
 
BACKGROUND 
Melasma is an acquired, chronic hyper-
melanosis condition that can cause aesthe-
tic disorders and decrease the patients’ qua-
lity of life. Melasma is common in women 
of reproductive age of all races and is 
characterized by symmetrical, homogenous 
and irregular brown macules in areas 
exposed to sunlight, especially the face 
(Tamega et al, 2013). Epidemiological data 
in the Cosmetic Dermatology Clinic of Der-
matology and Venereology Department in 
Dr. Cipto Mangunkusumo Hospital, Jakarta 
in 2011 showed the number of melasma 
patients was 18.1% of the total 3,763 visits, 
with a distribution of 98.4% was female 
patients and the remaining 1.6% was male 
(Melyawati et al, 2014). 
The pathogenesis of melasma is still 
unclear, but the factors of genetic, hormo-
nal, and ultraviolet (UV) radiation are 
thought to play a role. Other factors that are 
thought to contribute to the occurrence of 
melasma are the use of phototoxic drugs, 
anticonvulsant drugs, and the use of certain 
cosmetics (Moubasher et al, 2014). Various 
therapeutic modalities have been used to 
treat melasma, including bleaching agents, 
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chemical peeling, and various laser therapy 
(Choi et al, 2015). Melasma often does not 
improve with chemical peeling therapy or 
topical therapies such as hydroquinone, 
retinoid, azelaic acid or kojic acid due to 
resistance to these agents and rapid recur-
rence in the formation of melasma lesions 
(Sim et al, 2015). Since 2006, the use of 
low-fluence 1064-nm Q-switched Neody-
mium: Yttrium-Aluminum-Garnet (QS Nd-
YAG), a technique known as "laser toning", 
became popular for melasma therapy. 
Although said to be effective, this Nd-YAG 
QS laser can cause hypopigmentation in 
some patients(Kim et al, 2013) 
In this case report a 54-year-old 
woman with mixed-type melasma will be 
treated with a 1064-nm low-fluence Q-
switched Neodymium-Yttrium-Aluminum-
Garnet laser. 
 
CASE PRESENTATION 
A 54-year-old woman came to the Derma-
tology and Venereology Clinic of Dr. Saiful 
Anwar Hospital Malang, with complaint of 
dark spots on his face. These spots have 
appeared since 1 year ago. Spots initially 
appear in the nose area, then spread to the 
right and left cheeks and forehead. The 
spots do not feel itchy, hot, or painful. 
Before the spots appear the patient denies 
the presence of acne or irritation in the 
area. One month before going to the hos-
pital the patient visited his son who lived in 
Kalimantan and the patient felt his spots 
darken. 
Patient is a housewife. Besides doing 
household activity, she also actively partici-
pating in the recitation around the house. 
The patient said that she had routinely used 
cream from a beauty clinic >5 years. About 
4 months ago the patient changed her 
beauty clinic and got a morning and night 
cream. The creams are used for 2.5 months. 
The patient said there was no change in the 
spots. The past month, she has not used any 
treatment cream. Patients said she never 
wear sunscreen routinely every day. 
The patient has 2 children. Between 
the first and the second child, she used 
implant contraceptive for 5 years. After the 
birth of the second child, she underwent 
tubectomy. The patient said that she had 
never taken hormonal drugs such as birth 
control pills or other drugs on a regular 
basis. The patient said that neither the 
patient's mother nor the patient's brother 
had the same complaints as the patient. 
 
RESULTS 
On physical examination the patient's blood 
pressure was obtained 120/80 mmHg, with 
a pulse of 68x/ min, a respiratory rate of 
20x / min, and a temperature of 36.7oC. On 
dermatological examination on the face at 
centrofacial area, patches and macules of 
dark brown color with firm boundaries and 
irregular shapes are found. On examination 
with Wood's lamp, it was found that there 
were some spots with firm boundaries and 
other spots with unclear boundaries. 
Figure 1 depicted dermatological 
examination. Figure 1 showed dark brown 
patches and macules with firm borders and 
irregular shapes at the centro facial part of 
the face. 
Figure 2 depicted wood lamp exami-
nation. Figure 2 obtained some spots with 
firm boundaries and other spots with 
indefinite boundaries. 
The patient was diagnosed with 
mixed-type melasma. Patients were then 
planned to get low-fluence laser therapy Q-
Switch Neodymium Yttrium Aluminum 
Garnet 1064 nm every 2 weeks. During the 
laser therapy period patients are required 
to wear wide-spectrum sunscreen with SPF 
30 at least 2 times per day. Patients pro-
vided written informed consent to partici-
pate in the study. 
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Figure 1  A, B, C. Dermatological examination.  
 
 
Figure 2 A, B, C. Wood lamp examination 
 
 
Figure 3. Follow up of therapy. A. 4th week B. 2nd week C. 4th week D. 6th week 
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Before laser therapy, the patient is given 
topical anesthesia with 2.5% lidocaine and 
2.5% prilocaine for 30-45 minutes. After 
that topical anesthesia was cleaned with 
sterile gauze moistened with 0.9% NaCl. 
Patients received QS: Nd-YAG laser therapy 
with a wavelength of 1064 nm, spot size of 
8 mm, fluence 2.0 J / cm2, and 3 times fit 
the entire face. The end point of this thera-
py is the presence of erythema on the skin 
and warm palpable skin. After therapy, a 
cold compress with 0.9% NaCl is applied to 
reduce the patient's burning sensation. 
Laser therapy is performed every 2 weeks. 
 
 
Figure 4. The improvement of mMASI value 
 
At the time of initial examination, the 
modified MASI (mMASI) score was 8.4. 
Two weeks after the first laser, the mMASI 
score decreased by 2.2, so the score on the 
second week became 6.2. In the fourth 
week the score dropped again to 4.6 and in 
the sixth week the mMASI score remained 
4.6 (Figure 4). 
 
 
Figure 5. The improvement of VAS values 
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To evaluate patient satisfaction, 
Visual Analogue Scale (VAS) is used in the 
range 0-10, where 0 is no improvement and 
10 is a very satisfying improvement. Eva-
luation was carried out at weeks 0, 2, 4, 6, 
and 8. VAS values obtained were 2, 5, 6, 
and 8. There were no significant side effects 
in patients (Figure 5). 
 
DISCUSSION 
Melasma is a chronic condition of hyper-
melanosis obtained on the skin, which is 
characterized by brown macules with irre-
gular shapes and symmetrically distributed 
in areas of the body exposed to sunlight, 
especially the face(Handel et al, 2014). This 
disorder occurs most commonly between 
the ages of 30 and 40 years. Family history 
affects the occurrence of melasma in people 
with Fitzpatrick skin types II and III, 
whereas in darker skin types family history 
has no effect. Melasma is more common in 
female with a ratio of 9: 1 compared to 
male. In Southeast Asia the prevalence in 
adult women reaches 40% and in adult men 
20% (Cestari et al, 2017). 
Several studies have shown that there 
are increasing in both melanocytosis and 
melanogenesis in melasma patients. Some 
factors that can be triggers include sun 
exposure, use of oral contraceptives, thy-
roid disease, pregnancy, and medications 
(Sarkar et al, 2014). Study conducted by 
KrupaShankar et al in India shows that the 
most dominant trigger factor for melasma 
is sun exposure(KrupaShankar et al, 2014). 
Facial melasma can be divided into 3 
patterns based on the affected face area, 
namely centro facial pattern, malar pattern, 
and mandible pattern. In the centro facial 
pattern the affected area is the forehead, 
cheeks, upper lip, nose, and chin. Whereas 
in malar pattern the lesions are only found 
on the cheeks and nose, and in the pattern 
of the mandible the area involved is the 
ramus of the mandible(Rigopoulos et al, 
2017). While based on the depth of the pig-
ment, the type of melasma is divided into 
three, namely the dermal type, epidermal 
type, and mixed type. On Wood's lamp exa-
mination, dermal-type melasma is clearer 
and darker, while in the dermal type less 
fluorescence can be captured. The depth of 
the pigmentation also affects melasma 
therapy. In epidermal type, the response to 
therapy is better than the dermal type. And 
in mixed types, the response produced is 
only partial (Sarkar et al, 2014). In this case 
report found melasma in 54 years old 
woman. Patients never use sunscreen. Der-
matological examination revealed brownish 
macules in the centro facial area and 
Wood's lamp examination showed mixed 
type. 
The treatment of melasma consists of 
medical and non-medical therapy. In medi-
cal management can be given topical drugs, 
systemic drugs, and minimally and invasive 
treatment such as lasers and light and che-
mical peeling. Non-medical management 
can be topical such as skin care products, 
decorative cosmetics, or skin lightening 
cosmetics, and can also be systemic for 
example consumption of antioxidants 
(Wasitaadmaja et al, 2018). 
Laser therapy in pigmented lesions is 
based on the theory of selective photother-
molysis proposed by Anderson and Parrish. 
The theory states that when specific energy 
wavelengths are released in a shorter period 
of time than the thermal relaxation time 
(TRT) of the target chromophore, the ener-
gy will be retained in the target cell and 
cause less damage to the surrounding area 
(Arora et al, 2012). Laser quality-switched 
(Q-switched) produces high-intensity laser 
beams with very short pulse durations. The 
new variant of Q-switched laser is known as 
low fluence or Q-switched sub-termolytic 
therapy(Trivedi et al, 2017). Fluence used in 
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sub-termolytic laser therapy is <5 J / cm2 
(Wattanakrai et al, 2010). Low fluence thera-
py using a wavelength of 1064 nm (QS: Nd-
YAG) can penetrate deeper into the dermis 
and a little affects the epidermis (Trivedi et 
al, 2017). 
The selection of the right beam dia-
meter or spot size is important in the treat-
ment of pigmented lesions. Large spot sizes 
are safer for the epidermis and are pre-
ferred for dark skin types (Small et al, 
2016). Spot sizes between 7-10 mm produce 
maximum penetration to the dermis tissue. 
Deeper penetration will not be achieved if 
the spot size is above 10-12 mm(Nouri, 
2014). 
Patients were given a 1064 nm Q-
switched Nd-YAG laser therapy with 2 J / 
cm2 fluence, 8 mm spot size, and 3 passes. 3 
laser sessions with a 2-week interval 
showed improvement in the lesion marked 
by a decrease in the mMASI score and an 
increase in the VAS score. There were no 
laser side effects in patients, either hyper-
pigmentation, hypopigmentation, or the 
presence of scars.  
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